Eric Shinohara, MD, MSCI, discusses the potential to combine stereotactic body radiotherapy with immunotherapy in prostate cancer.
Eric Shinohara, MD, MSCI
Advertisement
Articles by Eric Shinohara, MD, MSCI
Eric Shinohara, MD, MSCI, discusses radiation therapy considerations for patients with prostate cancer.
Eric Shinohara, MD, MSCI, discusses the toxicities associated with stereotactic body radiotherapy in prostate cancer.
Eric Shinohara, MD, MSCI, discusses the future of stereotactic body radiation and surgery in prostate cancer.
Eric Shinohara, MD, MSCI, discusses the emergence of stereotactic body radiotherapy to treat patients with prostate cancer.
Advertisement
Latest Updated Articles
Dr. Shinohara on the Future of Radiation and Surgery in Prostate CancerPublished: January 25th 2020 | Updated:
Dr. Shinohara on Toxicities of Stereotactic Body Radiotherapy in Prostate CancerPublished: January 30th 2020 | Updated:
Dr. Shinohara on Radiation Therapy Considerations in Prostate CancerPublished: April 28th 2020 | Updated:
Dr. Shinohara on Pairing SBRT With Immunotherapy in Prostate CancerPublished: May 8th 2020 | Updated:
Dr. Shinohara on Stereotactic Body Radiotherapy to Treat Prostate CancerPublished: November 26th 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5